These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32976855)

  • 21. Statins: Could an old friend help in the fight against COVID-19?
    Rodrigues-Diez RR; Tejera-Muñoz A; Marquez-Exposito L; Rayego-Mateos S; Santos Sanchez L; Marchant V; Tejedor Santamaria L; Ramos AM; Ortiz A; Egido J; Ruiz-Ortega M
    Br J Pharmacol; 2020 Nov; 177(21):4873-4886. PubMed ID: 32562276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of statins on coronary artery disease. Review of the recent publications].
    Bednarz B
    Przegl Lek; 2003; 60(1):27-9. PubMed ID: 12884643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥ 80 years of age: observations from the CREDO-Kyoto Registry Cohort-2.
    Natsuaki M; Morimoto T; Furukawa Y; Shiomi H; Ono K; Kimura T;
    Atherosclerosis; 2014 Dec; 237(2):821-8. PubMed ID: 25463128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence.
    Adam S; Ho JH; Bashir B; Iqbal Z; Ferdousi M; Syed AA; Soran H
    Curr Opin Lipidol; 2021 Aug; 32(4):231-243. PubMed ID: 34116544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?
    Vuorio A; Kovanen PT
    J Intern Med; 2021 Oct; 290(4):931-933. PubMed ID: 34133038
    [No Abstract]   [Full Text] [Related]  

  • 28. Statins and SARS-CoV-2 disease: Current concepts and possible benefits.
    Minz MM; Bansal M; Kasliwal RR
    Diabetes Metab Syndr; 2020; 14(6):2063-2067. PubMed ID: 33120281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
    Verrall GM
    Front Immunol; 2020; 11():2167. PubMed ID: 33013911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Statins--new mechanisms of action and new indications].
    Savolainen M
    Duodecim; 2000; 116(24):2833-8. PubMed ID: 12077889
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes and cardiovascular disease: when it comes to lipids, statins are all you need.
    Bitzur R
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S380-2. PubMed ID: 21525486
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.
    Surma S; Banach M; Lewek J
    Lipids Health Dis; 2021 Oct; 20(1):141. PubMed ID: 34689776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin treatment in patients with metabolic syndrome and coronary artery disease.
    Ishihara M
    Circ J; 2009 Nov; 73(11):2013-4. PubMed ID: 19851028
    [No Abstract]   [Full Text] [Related]  

  • 36. Statins in coronary artery disease: beyond cholesterol reduction.
    Gambhir DS; Gambhir J
    Indian Heart J; 1997; 49(3):257-61. PubMed ID: 9291645
    [No Abstract]   [Full Text] [Related]  

  • 37. Fixed dose combination therapy and CVD protection: "a need of the hour".
    Chopra HK
    Indian Heart J; 2009; 61(4):316-21. PubMed ID: 20635732
    [No Abstract]   [Full Text] [Related]  

  • 38. Validating the benefits of lipid modifying therapies upon atherosclerotic plaque by computed tomography angiography: should we trust our eyes? Commentary on the study of Zeb et al.
    Rached FH; Santos RD
    Atherosclerosis; 2013 Dec; 231(2):189-90. PubMed ID: 24267224
    [No Abstract]   [Full Text] [Related]  

  • 39. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).
    Subir R; Jagat J M; Kalyan K G
    Diabetes Metab Syndr; 2020; 14(5):1225-1229. PubMed ID: 32683320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Case Against Coronary Artery Calcium Scoring for Cardiovascular Disease Risk Assessment.
    Mandrola J; Foy A
    Am Fam Physician; 2019 Dec; 100(12):734-735. PubMed ID: 31845777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.